Download Free Sample
Author
Prem Kumar with profound experience and sound knowledge across a wide range of market forecasting methods, demand f.....
Isoflavones Market size was valued at US$ 17.2 billion in 2023, poised to grow at a CAGR of 15% from 2024-2030. Isoflavones are phytoestrogen which are mainly produced by legume family plants such as soybeans, chickpeas, and red clover. Phytoestrogens are as similar to that of female hormones which are essential for the lowering cholesterol, treating cancers and menopausal symptoms, maintaining bone health, and others. Additionally, rising prevalence of cancer and rising in the number of geriatric population rising in the demand of good dietary products for the maintenance of health.
They are the key source of antioxidants which are used for lowering the cholesterol level which prevent from stroke and heart disease. Moreover, rising use of isoflavones in the manufacturing of cosmetics products as it has the property of antiaging such as reducing wrinkles, scars, etc. In addition, high growth in emerging economies provides huge growth opportunity for the market. Global isoflavones market is surging owing to frequent acquisitions and launchings by the market players.
Study Period
2024-2030Base Year
2023CAGR
4.2%Largest Market
North AmericaFastest Growing Market
Asia-Pacific
Some of the key factors influencing the market growth include growing demand for isoflavones as it a crucial for maintenance of health. Huge demand for plants based nutritional products and processed food. Additionally, increase in acceptance of isoflavones as a dietary food supplement and technological advancement in the biotechnology for launching new products boosting the market growth. However, volatile prices of isoflavones and its derivatives and side effect issues are the major factors hindering the market growth.
Global isoflavones market report gives comprehensive outlook on isoflavones across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America accounted for larger revenue share in global isoflavones market with considerable CAGR. The growth in this region can be attributed to rising demand for healthcare products and emerging economies. Also, rising awareness among European customers about the benefits offered by isoflavones and increasing number of healthcare industries are the other important factor responsible for the market growth. Asia Pacific held significant market share during estimated period as the rapid growing manufacturing industries, government strict regulation for public healthcare and key manufacturers are adopting various strategies for the expansion are of the market in the region.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 17.2 billion |
|
Market CAGR |
4.2% |
|
By Form |
|
|
By Source |
|
|
By Application |
|
|
By Region |
|
Download Free Sample Report
The isoflavones market size was valued at US$ 17.2 billion in 2023.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
| 1.Executive Summary |
| 2.Global Isoflavones Market Introduction |
| 2.1.Global Isoflavones Market - Taxonomy |
| 2.2.Global Isoflavones Market - Definitions |
| 2.2.1.Form |
| 2.2.2.Source |
| 2.2.3.Application |
| 2.2.4.Region |
| 3.Global Isoflavones Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Isoflavones Market Analysis, 2019-2023 and Forecast 2024-2030 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Isoflavones Market By Form, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 5.1. Powder |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Liquid |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Isoflavones Market By Source, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 6.1. Red Clover |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Soy |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Others (Green Peas, chickpeas and Alfalfa) |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Isoflavones Market By Application, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 7.1. Cosmetics |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Nutraceuticals |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Pharmaceuticals |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Food & Beverages |
| 7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Global Isoflavones Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Isoflavones Market 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 9.1. Form Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Powder |
| 9.1.2.Liquid |
| 9.2. Source Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Red Clover |
| 9.2.2.Soy |
| 9.2.3.Others (Green Peas, chickpeas and Alfalfa) |
| 9.3. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Cosmetics |
| 9.3.2.Nutraceuticals |
| 9.3.3.Pharmaceuticals |
| 9.3.4.Food & Beverages |
| 9.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Isoflavones Market 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 10.1. Form Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Powder |
| 10.1.2.Liquid |
| 10.2. Source Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Red Clover |
| 10.2.2.Soy |
| 10.2.3.Others (Green Peas, chickpeas and Alfalfa) |
| 10.3. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Cosmetics |
| 10.3.2.Nutraceuticals |
| 10.3.3.Pharmaceuticals |
| 10.3.4.Food & Beverages |
| 10.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 10.4.7. |
| 11.Asia Pacific (APAC) Isoflavones Market 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 11.1. Form Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Powder |
| 11.1.2.Liquid |
| 11.2. Source Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Red Clover |
| 11.2.2.Soy |
| 11.2.3.Others (Green Peas, chickpeas and Alfalfa) |
| 11.3. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Cosmetics |
| 11.3.2.Nutraceuticals |
| 11.3.3.Pharmaceuticals |
| 11.3.4.Food & Beverages |
| 11.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Isoflavones Market 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 12.1. Form Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Powder |
| 12.1.2.Liquid |
| 12.2. Source Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Red Clover |
| 12.2.2.Soy |
| 12.2.3.Others (Green Peas, chickpeas and Alfalfa) |
| 12.3. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Cosmetics |
| 12.3.2.Nutraceuticals |
| 12.3.3.Pharmaceuticals |
| 12.3.4.Food & Beverages |
| 12.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Isoflavones Market 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 13.1. Form Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Powder |
| 13.1.2.Liquid |
| 13.2. Source Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Red Clover |
| 13.2.2.Soy |
| 13.2.3.Others (Green Peas, chickpeas and Alfalfa) |
| 13.3. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Cosmetics |
| 13.3.2.Nutraceuticals |
| 13.3.3.Pharmaceuticals |
| 13.3.4.Food & Beverages |
| 13.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Cargill (Germany) |
| 14.2.2.ADM (US) |
| 14.2.3.BASF (Germany) |
| 14.2.4.DSM (Netherlands) |
| 14.2.5.International Flavors and Fragrances (Frutarom) (US) |
| 14.2.6.Shanghai Freemen (US) |
| 14.2.7.Nexira Inc. (France) |
| 14.2.8.Frutarom (Isarael) |
| 14.2.9.Xena Bio Herbals Pvt. Ltd. (India) |
| 14.2.10.Sikko Industries (India) |
| 14.2.11.SK Bioland (South Korea) |
| 14.2.12.BioMax (India) |
| 14.2.13.Avestia Pharma (India) |
| 14.2.14.NutraScience Labs (US) |
| 14.2.15.Tradichem S.L. (Spain) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Prem Kumar with profound experience and sound knowledge across a wide range of market forecasting methods, demand forecasting, and pricing analysis, I am able to make precise projections. I have extensive practical knowledge in Time Series Analysis (TSA), Simple Linear Regression (SLR), Multiple Linear Regression (MLR), Seasonality & Trend Forecasting, and Forecasting Models for New Products, among others. Additionally, I have hands-on experience with tools such as Power BI and SQL. I am highly committed, self-motivated, and possess a strong entrepreneurial spirit. Over the past 8 years, my team and I have built a robust clientele in various sectors, including Packaging, Pharma, Medical Devices, Oil & Gas, and Chemicals & Materials. We have provided a wide range of services, from management consulting to market forecasting and survey-related projects. I am particularly proud to have provided consulting services to one of the industry’s leading COVID-19 vaccine manufacturers for a packaging-related project. In the packaging space, I have served clients across a range of segments, including packaging printing, consumer packaging, flexible packaging, rigid packaging, and pharmaceutical packaging, to name a few. I deeply appreciate the efforts of my team and am grateful to our clients for their continued trust.